Increased nitric oxide levels and iNOS over-expression in oral squamous cell carcinoma
Authors:
- Maricris Macabeo-OngMMMaricris Macabeo-Ong
- Nusi DekkerNDNusi Dekker
- Richard C.K. JordanRJRichard C.K. Jordan
- Brian L. SchmidtBSBrian L. Schmidt
- 1 March 2005
- journal article
- Published by Elsevier in Oral Oncology
- Vol. 41 (3) , 261-267
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Proteasome-Mediated Degradation of p21 via N-Terminal UbiquitinylationCell, 2003
- Effect of Duration of Fixation on Quantitative Reverse Transcription Polymerase Chain Reaction AnalysesLaboratory Investigation, 2002
- Increased expression of inducible nitric oxide synthase for human buccal squamous‐cell carcinomas: Immunohistochemical, reverse transcription–polymerase chain reaction (RT‐PCR) and in situ RT‐PCR studiesHead & Neck, 2002
- Type II nitric oxide synthase (NOS2) expression correlates with lymph node status in oral squamous cell carcinomaJournal of Oral Pathology & Medicine, 2001
- Nitric Oxide Synthase Inhibition by NG-Nitro-l-Arginine Methyl Ester Inhibits Tumor-Induced Angiogenesis in Mammary TumorsThe American Journal of Pathology, 1999
- Inducible nitric oxide synthase: what difference does it make?Journal of Clinical Investigation, 1997
- Evidence for nitric oxide generation in the cardiomyocytes: its augmentation by hypoxiaJournal of Molecular and Cellular Cardiology, 1995
- Nitric oxide evokes pain in humans on intracutaneous injectionNeuroscience Letters, 1994
- Calmodulin is a subunit of nitric oxide synthase from macrophages.Journal of Experimental Medicine, 1992
- Relation of neovascularisation to metastasis of non-small-cell lung cancerThe Lancet, 1992